logo
AI eroded doctors' ability to spot cancer within months in study

AI eroded doctors' ability to spot cancer within months in study

Straits Times2 days ago
Sign up now: Get ST's newsletters delivered to your inbox
A researcher predicted that the effects of de-skilling will 'probably be higher' as AI becomes more powerful.
LONDON – Artificial intelligence, touted for its potential to transform medicine, led to some doctors losing skills after just a few months in a new study.
AI helped health professionals to better detect pre-cancerous growths in the colon, but when the assistance was removed, their ability to find tumours dropped by about 20 per cent compared with rates before the tool was ever introduced, according to findings published on Aug 13.
Health-care systems around the world are embracing AI with a view to boosting patient outcomes and productivity.
The UK government in 2025 announced £11 million (S$19.06 million) in funding for a new trial to test how AI can help catch breast cancer earlier.
The AI in the study probably prompted doctors to become over-reliant on its recommendations, 'leading to clinicians becoming less motivated, less focused, and less responsible when making cognitive decisions without AI assistance,' the scientists said in the paper.
They surveyed four endoscopy centres in Poland and compared detection success rates three months before AI implementation and three months after. Some colonoscopies were performed with AI and some without, at random.
The results were published in The Lancet Gastroenterology and Hepatology journal.
Professor Yuichi Mori, a researcher at the University of Oslo and one of the scientists involved, predicted that the effects of de-skilling will 'probably be higher' as AI becomes more powerful.
What's more, the 19 doctors in the study were highly experienced, having performed more than 2,000 colonoscopies each.
The effect on trainees or novices might be starker, said Dr Omer Ahmad, a consultant gastroenterologist at University College Hospital London.
'Although AI continues to offer great promise to enhance clinical outcomes, we must also safeguard against the quiet erosion of fundamental skills required for high-quality endoscopy,' Dr Ahmad, who wasn't involved in the research, wrote a comment alongside the article.
A study conducted by MIT in 2025 raised similar concerns after finding that using OpenAI's ChatGPT to write essays led to less brain engagement and cognitive activity. BLOOMBERG
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NTUC's e2i trialling one-stop portal with AI tools to help jobseekers
NTUC's e2i trialling one-stop portal with AI tools to help jobseekers

CNA

time2 hours ago

  • CNA

NTUC's e2i trialling one-stop portal with AI tools to help jobseekers

Since April 2024, more than 7,000 jobseekers have used artificial intelligence tools through the National Trades Union Congress' Employment and Employability Institute (e2i) to build resumes and practise for interviews. A new one-stop portal, called the AI Career Coach, is being trialled to help users better understand the job market and apply for suitable roles. e2i said these tools seek to boost employability, especially for first-time jobseekers. Nadirah Zaidi reports.

AI startup Cohere valued at $6.8 billion in latest fundraise, appoints new executives
AI startup Cohere valued at $6.8 billion in latest fundraise, appoints new executives

CNA

time2 hours ago

  • CNA

AI startup Cohere valued at $6.8 billion in latest fundraise, appoints new executives

Cohere was valued at $6.8 billion after its latest $500 million funding round, as the artificial intelligence startup moves to expand its market share in a highly competitive industry. The funding round was led by Radical Ventures and Inovia Capital, with participation from existing investors AMD Ventures, NVIDIA, PSP Investments, and Salesforce Ventures, among others. Unlike most AI companies like OpenAI and Meta's Llama, which are focused on broad foundational models, Cohere builds enterprise-specific AI models. In January, it launched North, a ChatGPT-style tool designed to help knowledge workers with tasks such as document summarization. The company said it will use the new funding to advance agentic AI that can help businesses and governments operate more efficiently. Alongside the fundraise, Cohere appointed Joelle Pineau, former Vice President of AI Research at Meta, as Chief AI Officer, and Francois Chadwick, former CFO at Uber and Shield AI, as Chief Financial Officer. The fundraise comes amid a broader surge in AI financing, as private equity and Big Tech channel capital into startups in pursuit of strong returns from innovative AI products.

HSA working with HK's Department of Health to tackle vaping by exchanging enforcement ideas
HSA working with HK's Department of Health to tackle vaping by exchanging enforcement ideas

Straits Times

time5 hours ago

  • Straits Times

HSA working with HK's Department of Health to tackle vaping by exchanging enforcement ideas

Sign up now: Get ST's newsletters delivered to your inbox The MOU for cooperation in healthcare regulatory matters comes as Singapore and Hong Kong are each tackling the vaping scourge in their jurisdictions. SINGAPORE – The Health Sciences Authority (HSA) is working with Hong Kong's Department Of Health (DOH) to tackle vaping by exchanging information and expertise with each other. In a statement on Aug 13, HSA said it signed a memorandum of understanding (MOU) with the DOH for cooperation in healthcare regulatory matters involving health products. This comes as Singapore and Hong Kong are each tackling the vaping scourge in their respective jurisdictions. Health Minister Ong Ye Kung was among the officials who witnessed the MOU signing at the Ministry of Health, College of Medicine Building. Mr Ong had said in July that Singapore was working to list etomidate, which is being abused via vapes, under the Misuse of Drugs Act. This paves the way for abusers and traffickers of Kpods – vapes containing etomidate – to be treated in the same way as those who abuse or traffic drugs, with mandatory rehabilitation and jail time for repeat offenders. On Aug 13, HSA said the MOU includes technical cooperation and the exchange of information, best practices and expertise relating to healthcare regulatory matters involving health products. Top stories Swipe. Select. Stay informed. Singapore Over 100 people being investigated for vape offences, say MOH and HSA Singapore Bukit Merah fire: Residents relocated as town council carries out restoration works Singapore askST: What to do in the event of a fire at home Singapore Jalan Bukit Merah fire: PMD battery could have started fatal blaze, says SCDF Singapore askST: What are the fire safety rules for PMDs? Asia AirAsia flight from KL to Incheon lands at wrong airport in South Korea Opinion Could telco consolidation spell the end of attractive mobile plans? Singapore From quiet introvert to self-confident student: How this vulnerable, shy teen gets help to develop and discover her strength These include pharmaceuticals, medical devices, advanced therapy products and traditional medicines. HSA said: 'The agreement also facilitates the sharing of regulatory information and enforcement approaches towards tobacco products and vaping devices.' The MOU will enable the exchange of regulatory experts and staff, participation in meetings and scientific conferences, and collaboration in training courses and joint projects. HSA chief executive officer, Adjunct Professor (Dr) Raymond Chua, said: 'This partnership represents a significant step forward in regulatory cooperation between Singapore and Hong Kong. 'By combining our expertise and sharing best practices, we can better tackle the emerging challenges in healthcare regulation, harness opportunities and strengthen public health protection in both jurisdictions.' Also on Aug 13, The Straits Times reported that HSA had recently advertised job openings for investigators specifically to crack down on Kpods. Singapore and Hong Kong are both grappling with a vape scourge involving e-vaporisers laced with etomidate, a controlled anaesthetic meant only for use in medical procedures. In Hong Kong, the drug was first marketed as space oil with peddlers promising users a euphoric high that would 'take them to space'. Its government referred to it as 'space oil drug' in February, after the authorities recognised the severity of the problem when several addicts died, and children as young as nine years old were taking the substance. On July 31, the government renamed the problem 'etomidate' to eradicate the positive misconceptions of the drug. Hong Kong will ban the possession and use of vapes in public by mid-2026. Meanwhile, Singapore has ramped up efforts to tackle vapes and Kpods. The anti-vaping blitz here has extended to areas near schools, with enforcement officers conducting checks outside institutes of higher learning. On July 25, the Ministry of Health, HSA and the People's Association launched the 'Bin The Vape' initiative. This allows members of the public to throw away vapes in bins installed within community centres and universities around Singapore without fear of punishment. On July 30, Home Affairs Minister K. Shanmugam, who is also Coordinating Minister for National Security, said his ministry will second its officers to HSA. Aside from enforcement, they will also help in the supervision, treatment and rehabilitation of abusers. The public can report vaping offences to the Tobacco Regulation Branch at 6684-2036 or 6684-2037 from 9am to 9pm daily, or online at Those who need help to quit vaping can join the Health Promotion Board's I Quit programme by calling the QuitLine on 1800-438-2000. The authorities have said those who voluntarily seek support to quit vaping will not face any penalties for doing so.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store